Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics

AM Grimaldi, M Incoronato, M Salvatore… - Nanomedicine, 2017 - Taylor & Francis
Although recent successes in clinical trials are strengthening research focused on cancer
immunology, the poor immunogenicity and off-target side effects of immunotherapeutics …
被引用次数：67 相关文章

Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics

AM Grimaldi, M Incoronato… - Nanomedicine …, 2017 - pubmed.ncbi.nlm.nih.gov
Although recent successes in clinical trials are strengthening research focused on cancer
immunology, the poor immunogenicity and off-target side effects of immunotherapeutics …

Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics

AM Grimaldi, M Incoronato, M Salvatore… - …, 2017 - ricerca.uniparthenope.it
Although recent successes in clinical trials are strengthening research focused on cancer
immunology, the poor immunogenicity and off-target side effects of immunotherapeutics …

Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics

AM Grimaldi, M Incoronato, M Salvatore… - …, 2017 - search.proquest.com
Although recent successes in clinical trials are strengthening research focused on cancer
immunology, the poor immunogenicity and off-target side effects of immunotherapeutics …

Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.

AM Grimaldi, M Incoronato, M Salvatore… - Nanomedicine (London …, 2017 - europepmc.org
Although recent successes in clinical trials are strengthening research focused on cancer
immunology, the poor immunogenicity and off-target side effects of immunotherapeutics …

Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics

AM Grimaldi, M Incoronato, M Salvatore, A Soricelli - Nanomedicine, 2017 - cir.nii.ac.jp
抄録< jats: p> Although recent successes in clinical trials are strengthening research
focused on cancer immunology, the poor immunogenicity and off-target side effects of …